The study will determine the optimal dosing regimen of LNA043 in patients with knee osteoarthritis (OA).
This study is a 2-period, multicenter, randomized, parallel-group, double-blind, placebo-controlled study consisting of a 2-year Core period, followed by a 3 year extension period. The primary objective of this study is to assess the efficacy of LNA043 compared to placebo at Week 104 as measured by the mean change from baseline in cartilage thickness using qMRI of the target knee
Injection to the knee
Injection to the knee
Injection to the knee
Injection to the knee
Injection to the knee
Ciudad Autonoma de Bs As, Argentina
Córdoba, Argentina
San Miguel de Tucumán, Argentina